Harry Bartelink
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Radiation top 0.1%
- Advanced Radiotherapy Techniques
Papers in
- Cancer Research 114
- Breast Cancer Treatment Studies 101
- Oncology 55
- Co-authors
- Marc J. van de Vijver (21 shared papers)Johannes L. Peterse (12 shared papers)Augustinus A. M. Hart (12 shared papers)M. Piérart (18 shared papers)Marcel Verheij (33 shared papers)Jean-Claude Horiot (26 shared papers)Hongyue Dai (2 shared papers)Yudong D. He (2 shared papers)
- Journals
- Radiotherapy and Oncology (68 papers)International Journal of Radiation Oncology*Biology*Physics (47 papers)European Journal of Cancer (31 papers)Journal of Clinical Oncology (14 papers)Breast Cancer Research and Treatment (5 papers)
- Partner nations
- NetherlandsBelgiumFrance
In The Last Decade
Harry Bartelink
267 papers receiving 24.6k citations
Harry Bartelink's Hit Papers
Peers
Comparison fields: 5 of 167
- Cancer Research 9.6k
- Radiation 2.0k
- Otorhinolaryngology 919
- Oncology 5.6k
- Pathology and Forensic Medicine 3.1k
Countries citing papers authored by Harry Bartelink
This map shows the geographic impact of Harry Bartelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Bartelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Bartelink more than expected).
Fields of papers citing papers by Harry Bartelink
This network shows the impact of papers produced by Harry Bartelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Bartelink. The network helps show where Harry Bartelink may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry Bartelink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Hit paper breakdown → | 2002 | 4717 |
| 2 | Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer Hit paper breakdown → | 1992 | 999 |
| 3 | Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. Hit paper breakdown → | 1997 | 905 |
| 4 | Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Hit paper breakdown → | 2005 | 735 |
| 5 | Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial Hit paper breakdown → | 2007 | 723 |
| 6 | Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation Hit paper breakdown → | 2001 | 691 |
| 7 | Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer Hit paper breakdown → | 2007 | 633 |
| 8 | Late cardiotoxicity after treatment for Hodgkin lymphoma Hit paper breakdown → | 2006 | 540 |
| 9 | Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease Hit paper breakdown → | 2003 | 506 |
| 10 | 2007 | 482 | |
| 11 | 2006 | 459 | |
| 12 | 2001 | 427 | |
| 13 | 2012 | 379 | |
| 14 | Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. | 1992 | 344 |
| 15 | 1995 | 311 | |
| 16 | Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801 Hit paper breakdown → | 1998 | 271 |
| 17 | 2000 | 252 | |
| 18 | 2013 | 245 | |
| 19 | 2000 | 241 | |
| 20 | 2007 | 237 |
About Harry Bartelink
Harry Bartelink is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 272 papers that have together received 25.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (101 papers), Advanced Radiotherapy Techniques (34 papers), Breast Lesions and Carcinomas (24 papers), Head and Neck Cancer Studies (21 papers), Lymphoma Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (14 papers), Advances in Oncology and Radiotherapy (13 papers) and Effects of Radiation Exposure (12 papers). The work is most often cited by research in Cancer Research (9.6k citations), Radiation (2.0k citations), Otorhinolaryngology (919 citations), Oncology (5.6k citations) and Pathology and Forensic Medicine (3.1k citations). Harry Bartelink has collaborated with scholars based in Netherlands, Belgium and France. Frequent co-authors include Marc J. van de Vijver, Johannes L. Peterse, Augustinus A. M. Hart, M. Piérart, Marcel Verheij, Jean-Claude Horiot, Hongyue Dai, Yudong D. He, Philip Poortmans and Alain Fourquet. Their work appears in journals such as Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Journal of Clinical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.